HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy.

Abstract
Here we report the first pediatric case of restrictive cardiomyopathy secondary to a de novo mutation in the cardiac myosin heavy chain gene MYH7. The clinical course is characterized by an early onset of disease, mild hypertrophy of the left ventricle and a very short evolution to death. Because of the location of the mutation in the hinge region between the rod part and the globular head of the myosin molecule, it is possible that restrictive cardiomyopathy resulted from an impairment of flexion/extension of myosin heads during the contraction/relaxation cycle.
AuthorsSimon Karam, Marie-Josée Raboisson, Corinne Ducreux, Lara Chalabreysse, Gilles Millat, André Bozio, Patrice Bouvagnet
JournalCongenital heart disease (Congenit Heart Dis) 2008 Mar-Apr Vol. 3 Issue 2 Pg. 138-43 ISSN: 1747-0803 [Electronic] United States
PMID18380764 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MYH7 protein, human
  • Cardiac Myosins
  • Myosin Heavy Chains
Topics
  • Cardiac Myosins (genetics)
  • Cardiomyopathy, Restrictive (diagnosis, genetics)
  • Fatal Outcome
  • Humans
  • Infant, Newborn
  • Male
  • Mutation
  • Myosin Heavy Chains (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: